The contract manufacturing arm of German pharmaceutical group Boehringer Ingelheim confirmed yesterday that the clinical trial materials supplied to TeGenero for use in the trial that left six men ...

TeGenero, the German firm whose monoclonal antibody drug TGN1412 was involved in a disastrous Phase I trial, has filed for bankruptcy. The tests, conducted in March by Parexel International, resulted ...

TeGenero, the German biotechnology company whose experimental drug caused the hospitalisation of six men earlier this week, has apologised to the victims and their families and confirmed that all ...

Lawyers acting for the six volunteers who suffered multiple organ failure during the trial of a new drug last month fear the men may not get full compensation because the company accepting liability ...

Two men were continuing to fight for their lives tonight after suffering an extreme reaction to a drug they were testing. They were in a critical condition in hospital while four others were "serious" ...

Proposals unlikely to remove the cloud surrounding first-in-human trials of many novel biologics You have full access to this article via your institution. The European Medicines Evaluation Agency ...

> Australia's Pharmaxis has begun a Phase III trial of Bronchitol, its experimental therapy for bronchiectasis. Results are expected by the mid-part of next year. Report > Chembio Diagnostics has ...